Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure.

June Hwa Bae Jung-Bin Park Ji Eun Baek Seung Wook Hong Sang Hyoung Park Dong-Hoon Yang Byong Duk Ye Seung Wook Hong Seung-Jae Myung Suk-Kyun Yang Sung Wook Hwang

Published in: Gut and liver (2024)

In UC patients who experience IV infliximab failure during maintenance treatment, switching to SC infliximab may be a promising option because of better efficacy and safety.

Keyphrases

ulcerative colitis
end stage renal disease
chronic kidney disease
ejection fraction
randomized controlled trial
newly diagnosed
systematic review
prognostic factors
high dose
combination therapy
replacement therapy
smoking cessation